THC blocked immune cell development by eliminating oxidative stress through a novel mechanism

THC prevented bone marrow cells from developing into macrophages by reducing reactive oxygen species through two pathways: activating antioxidant genes and chemically blocking the Fenton Reaction, independent of known cannabinoid receptors.

Carter, Taylor H et al.·Antioxidants (Basel·2024·Preliminary Evidencelaboratory
RTHC-05179LaboratoryPreliminary Evidence2024RETHINKTHC RESEARCH DATABASErethinkthc.com/research

Quick Facts

Study Type
laboratory
Evidence
Preliminary Evidence
Sample
Not reported

What This Study Found

THC blocked M-CSF-induced macrophage differentiation from bone marrow cells through a receptor-independent mechanism. RNA-seq showed upregulation of NRF2-ARE antioxidant genes. THC also directly prevented ROS formation via the Fenton Reaction. The effect was independent of CB1, CB2, GPR18, GPR55, and adenosine A2A receptors.

Key Numbers

THC blocked differentiation of CD45+CD11b+F4/80+ macrophages. Effect was independent of 5 known receptors (CB1, CB2, GPR18, GPR55, A2A). KEGG pathway analysis linked to ferroptosis and glutathione metabolism. THC-treated cells showed increased iron but decreased ROS.

How They Did This

Bone marrow-derived cells were cultured with M-CSF and THC. Flow cytometry tracked macrophage differentiation markers. RNA sequencing identified affected pathways. Receptor knockout and antagonist studies tested known cannabinoid receptors. Fluorescence assays measured intracellular iron and ROS levels.

Why This Research Matters

This study reveals a previously unknown way THC affects the immune system: by blocking the development of macrophages through antioxidant mechanisms independent of traditional cannabinoid receptors. This has implications for understanding how cannabis affects immune defense.

The Bigger Picture

Most research on THC and immunity focuses on cannabinoid receptor signaling. This finding that THC can block immune cell development through a completely receptor-independent antioxidant mechanism opens up new questions about how cannabis use might compromise immune surveillance.

What This Study Doesn't Tell Us

In vitro study using mouse bone marrow cells. The concentrations of THC used may not reflect physiological levels after cannabis use. Blocking macrophage development in a dish does not necessarily translate to impaired immunity in a living organism.

Questions This Raises

  • ?Does chronic cannabis use impair macrophage populations in humans?
  • ?Could this mechanism explain some of the immunosuppressive effects reported with heavy cannabis use?
  • ?Is the Fenton Reaction-blocking property unique to THC or shared by other cannabinoids?

Trust & Context

Key Stat:
THC effect was independent of all 5 tested cannabinoid receptors
Evidence Grade:
Preliminary in vitro study with rigorous mechanistic investigation. While the receptor-independent finding is novel, translation to whole-organism immunity requires further research.
Study Age:
Published in 2024 in Antioxidants.
Original Title:
Delta-9-Tetrahydrocannabinol Blocks Bone Marrow-Derived Macrophage Differentiation through Elimination of Reactive Oxygen Species.
Published In:
Antioxidants (Basel, Switzerland), 13(8) (2024)
Database ID:
RTHC-05179

Evidence Hierarchy

Meta-Analysis / Systematic Review
Randomized Controlled Trial
Cohort / Case-Control
Cross-Sectional / ObservationalSnapshot without intervening
This study
Case Report / Animal Study
What do these levels mean? →

Frequently Asked Questions

How does THC affect immune cells?

This study found THC prevents bone marrow cells from developing into macrophages (key immune defenders) by eliminating reactive oxygen species, which are normally needed for the differentiation process.

Does this mean cannabis weakens the immune system?

The study shows THC can block immune cell development in laboratory conditions, but whether this translates to meaningful immune impairment in cannabis users requires further research in living organisms.

Read More on RethinkTHC

Cite This Study

RTHC-05179·https://rethinkthc.com/research/RTHC-05179

APA

Carter, Taylor H; Weyer-Nichols, Chloe E; Garcia-Sanchez, Jeffrey I; Wilson, Kiesha; Nagarkatti, Prakash; Nagarkatti, Mitzi. (2024). Delta-9-Tetrahydrocannabinol Blocks Bone Marrow-Derived Macrophage Differentiation through Elimination of Reactive Oxygen Species.. Antioxidants (Basel, Switzerland), 13(8). https://doi.org/10.3390/antiox13080887

MLA

Carter, Taylor H, et al. "Delta-9-Tetrahydrocannabinol Blocks Bone Marrow-Derived Macrophage Differentiation through Elimination of Reactive Oxygen Species.." Antioxidants (Basel, 2024. https://doi.org/10.3390/antiox13080887

RethinkTHC

RethinkTHC Research Database. "Delta-9-Tetrahydrocannabinol Blocks Bone Marrow-Derived Macr..." RTHC-05179. Retrieved from https://rethinkthc.com/research/carter-2024-delta9tetrahydrocannabinol-blocks-bone-marrowderived

Access the Original Study

Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.

This study breakdown was produced by the RethinkTHC research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.